Antiviral efficacy of NS3‐serine protease inhibitor... : Hepatology (original) (raw)

Concise Communication

Antiviral efficacy of NS3‐serine protease inhibitor BILN‐2061 in patients with chronic genotype 2 and 3 hepatitis C†‡

Reiser, Markus*,1,§; Hinrichsen, Holger2; Benhamou, Yves3; Reesink, Henk W.4; Wedemeyer, Heiner5; Avendano, Cristina6; Riba, Neus7; Yong, Chan‐Loi9; Nehmiz, Gerhard8; Steinmann, Gerhard G.8

1Ruhr‐Universität Bochum, Bochum, Germany

2Medizinische Universitätsklinik, Kiel, Germany

3Groupe Hospitalier Pitié‐Salpetrière, Paris, France

4Academic Medical Center, Amsterdam, The Netherlands

5Medizinische Hochschule, Hannover, Germany

6Clinica Puerta de Hierro, Madrid, Spain

7Hospital Clinic, Barcelona, Spain

8Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany

9Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT

Ruhr‐Universität Bochum, Department of Gastroenterology & Hepatology, Berufsgenossenschaftliche Kliniken Bergmannsheil, Bürkle‐de‐la‐Camp‐Platz 1, D‐44789 Bochum, Germany===

Accepted January 05, 2004

Received September 22, 2004